Kenya - English - Pharmacy and Poisons Board

single-stranded, 5’-capped messenger rna (mrna)… - injection - 30 micrograms of covid-19 mrna vaccine (embedded… - covid-19 vaccines

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - raxtozinameran 0.1 mg/ml equivalent to 30µg/0.3ml dose;  ;   - suspension for injection - 0.1 mg/ml - active: raxtozinameran 0.1 mg/ml equivalent to 30µg/0.3ml dose     excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol sucrose trometamol trometamol hydrochloride water for injection - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 12 years of age and older. the use of this vaccine should be in accordance with official recommendations.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - raxtozinameran 0.1 mg/ml equivalent to 30µg/0.3ml dose;  ;   - suspension for injection - 0.1 mg/ml - active: raxtozinameran 0.1 mg/ml equivalent to 30µg/0.3ml dose     excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol sucrose trometamol trometamol hydrochloride water for injection - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 12 years of age and older. the use of this vaccine should be in accordance with official recommendations.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - raxtozinameran 0.033 mg/ml equivalent to 3µg/0.3ml dose;  ;   - concentrate for injection - 0.033 mg/ml - active: raxtozinameran 0.033 mg/ml equivalent to 3µg/0.3ml dose     excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol sucrose trometamol trometamol hydrochloride water for injection - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in infants and children aged 6 months to 4 years. the use of this vaccine should be in accordance with official recommendations.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - raxtozinameran 0.1 mg/ml equivalent to 3µg/0.2ml dose;  ;   - concentrate for injection - 0.1 mg/ml - active: raxtozinameran 0.1 mg/ml equivalent to 3µg/0.2ml dose     excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol sucrose trometamol trometamol hydrochloride water for injection - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in infants and children aged 6 months to 4 years. the use of this vaccine should be in accordance with official recommendations.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - raxtozinameran 0.1 mg/ml equivalent to 10µg/0.2ml dose;  ;   - concentrate for injection - 0.1 mg/ml - active: raxtozinameran 0.1 mg/ml equivalent to 10µg/0.2ml dose     excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol sucrose trometamol trometamol hydrochloride water for injection - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in children aged 5 to 11 years. the use of this vaccine should be in accordance with official recommendations.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - raxtozinameran 0.033 mg/ml equivalent to 10µg/0.3ml dose;  ;   - suspension for injection - 0.033 mg/ml - active: raxtozinameran 0.033 mg/ml equivalent to 10µg/0.3ml dose     excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol sucrose trometamol trometamol hydrochloride water for injection - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in children aged 5 to 11 years. the use of this vaccine should be in accordance with official recommendations.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - raxtozinameran 0.033 mg/ml equivalent to 10µg/0.3ml dose;  ;   - suspension for injection - 0.033 mg/ml - active: raxtozinameran 0.033 mg/ml equivalent to 10µg/0.3ml dose     excipient: 1,2-distearoyl-sn-glycero-3-phosphocholine alc-0159 alc-0315 cholesterol sucrose trometamol trometamol hydrochloride water for injection - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in children aged 5 to 11 years. the use of this vaccine should be in accordance with official recommendations.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pfizer laboratories (pty) ltd - injection - 30,0 μg - tozinameran

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

pfizer laboratories (pty) ltd - injection - 30,0 μg - tozinameran